Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JFL LIFE SCIENCES LTD. vs MANGALAM DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JFL LIFE SCIENCES LTD. MANGALAM DRUGS JFL LIFE SCIENCES LTD./
MANGALAM DRUGS
 
P/E (TTM) x - 52.4 - View Chart
P/BV x 2.7 1.2 224.5% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 JFL LIFE SCIENCES LTD.   MANGALAM DRUGS
EQUITY SHARE DATA
    JFL LIFE SCIENCES LTD.
Mar-24
MANGALAM DRUGS
Mar-24
JFL LIFE SCIENCES LTD./
MANGALAM DRUGS
5-Yr Chart
Click to enlarge
High Rs54132 40.4%   
Low Rs3691 39.8%   
Sales per share (Unadj.) Rs42.3232.8 18.2%  
Earnings per share (Unadj.) Rs3.0-5.7 -52.5%  
Cash flow per share (Unadj.) Rs3.43.5 96.8%  
Dividends per share (Unadj.) Rs0.250-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs32.385.8 37.7%  
Shares outstanding (eoy) m11.0015.83 69.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.10.5 221.0%   
Avg P/E ratio x14.9-19.4 -76.5%  
P/CF ratio (eoy) x13.131.6 41.5%  
Price / Book Value ratio x1.41.3 106.5%  
Dividend payout %8.30-   
Avg Mkt Cap Rs m4921,764 27.9%   
No. of employees `000NANA-   
Total wages/salary Rs m20391 5.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4653,686 12.6%  
Other income Rs m51 534.7%   
Total revenues Rs m4713,687 12.8%   
Gross profit Rs m45174 26.1%  
Depreciation Rs m4147 3.0%   
Interest Rs m8139 5.9%   
Profit before tax Rs m38-111 -34.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5-20 -24.6%   
Profit after tax Rs m33-91 -36.5%  
Gross profit margin %9.84.7 206.9%  
Effective tax rate %12.918.1 71.6%   
Net profit margin %7.1-2.5 -288.7%  
BALANCE SHEET DATA
Current assets Rs m4311,760 24.5%   
Current liabilities Rs m2001,641 12.2%   
Net working cap to sales %49.73.2 1,535.5%  
Current ratio x2.21.1 201.2%  
Inventory Days Days72 315.5%  
Debtors Days Days1,972277 712.7%  
Net fixed assets Rs m1341,577 8.5%   
Share capital Rs m110158 69.5%   
"Free" reserves Rs m2461,200 20.5%   
Net worth Rs m3561,358 26.2%   
Long term debt Rs m10134 7.3%   
Total assets Rs m5653,337 16.9%  
Interest coverage x5.60.2 2,740.6%   
Debt to equity ratio x00.1 28.0%  
Sales to assets ratio x0.81.1 74.6%   
Return on assets %7.31.5 503.7%  
Return on equity %9.3-6.7 -139.2%  
Return on capital %12.71.9 663.7%  
Exports to sales %00-   
Imports to sales %023.6 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA870 0.0%   
Fx inflow Rs m01,689 0.0%   
Fx outflow Rs m0879 0.0%   
Net fx Rs m0810 0.0%   
CASH FLOW
From Operations Rs m8439 213.6%  
From Investments Rs m-61-118 51.3%  
From Financial Activity Rs m-2352 -44.3%  
Net Cashflow Rs m0-27 0.9%  

Share Holding

Indian Promoters % 67.5 50.3 134.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.1 -  
FIIs % 0.0 0.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 32.5 49.7 65.5%  
Shareholders   966 19,508 5.0%  
Pledged promoter(s) holding % 0.0 10.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JFL LIFE SCIENCES LTD. With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on JFL LIFE SCIENCES LTD. vs MANGALAM DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

JFL LIFE SCIENCES LTD. vs MANGALAM DRUGS Share Price Performance

Period JFL LIFE SCIENCES LTD. MANGALAM DRUGS S&P BSE HEALTHCARE
1-Day -5.00% -0.38% 0.53%
1-Month 26.39% -5.69% -0.93%
1-Year -36.26% 9.26% 42.63%
3-Year CAGR -14.22% -5.52% 20.07%
5-Year CAGR -8.79% 27.32% 26.07%

* Compound Annual Growth Rate

Here are more details on the JFL LIFE SCIENCES LTD. share price and the MANGALAM DRUGS share price.

Moving on to shareholding structures...

The promoters of JFL LIFE SCIENCES LTD. hold a 67.5% stake in the company. In case of MANGALAM DRUGS the stake stands at 50.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of JFL LIFE SCIENCES LTD. and the shareholding pattern of MANGALAM DRUGS.

Finally, a word on dividends...

In the most recent financial year, JFL LIFE SCIENCES LTD. paid a dividend of Rs 0.3 per share. This amounted to a Dividend Payout ratio of 8.3%.

MANGALAM DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of JFL LIFE SCIENCES LTD., and the dividend history of MANGALAM DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.